Company intelligence / Profile preview
Hunan Jiudian Pharmaceutical Co., Ltd.
- Ownership
- Private
- Employees
- ~1893
- Development stage
- Commercial
Overview
Hunan Jiudian Pharmaceutical has a robust commercial portfolio with over one hundred products including APIs and finished dosage forms. It leads in percutaneous drug delivery systems like loxoprofen sodium gel plaster. The company’s R&D pipeline includes both chemical drugs and traditional Chinese medicines across multiple therapeutic areas. Over two dozen products have passed China’s drug consistency evaluation. Clinical trial results are not detailed publicly.
- Therapeutic areas
- PulmonologyWomen's HealthImmunologyGastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecules (APIs, finished dosage forms)Traditional Chinese medicines
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Hunan Jiudian Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hunan Jiudian Pharmaceutical Co., Ltd..